This article is missing information about everything. Please expand the article to include this information. Further details may exist on the talk page. (January 2017)

Clofibride

Clinical data
ATC code	C10AB10 (WHO)
Pharmacokinetic data
Metabolism	Hydrolyzed to clofibric acid; hepatic glucuronidation
Elimination half-life	12 hours (clofibric acid)
Excretion	Renal (mostly) and fecal
Identifiers
IUPAC name 3-(dimethylcarbamoyl)propyl 2-(4-chlorophenoxy)-2-methylpropanoate
CAS Number	26717-47-5
PubChem CID	160134
ChemSpider	140758 Y
UNII	0S9SLS3L93
KEGG	D07188 Y
ChEMBL	ChEMBL1697831
CompTox Dashboard (EPA)	DTXSID1022841
ECHA InfoCard	100.043.542
Chemical and physical data
Formula	C16H22ClNO4
Molar mass	327.81 g·mol−1
3D model (JSmol)	Interactive image
SMILES Clc1ccc(OC(C(=O)OCCCC(=O)N(C)C)(C)C)cc1
InChI InChI=1S/C16H22ClNO4/c1-16(2,22-13-9-7-12(17)8-10-13)15(20)21-11-5-6-14(19)18(3)4/h7-10H,5-6,11H2,1-4H3 Y Key:CXQGFLBVUNUQIA-UHFFFAOYSA-N Y
(verify)

Clofibride is a fibrate. Clofibride is a derivative of clofibrate. In the body it is converted into 4-chlorophenoxyisobutyric acid (clofibric acid),^[1] which is the true hypolipidemic agent.^[2] So clofibride, just like clofibrate is a prodrug of clofibric acid.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

• v
• t
• e